Octreotide is used to treat specific types of cancers, which are typically located in the intestines and pancreas. These tumours include carcinoid tumours and vasoactive intestinal peptide tumours, which can produce severe watery diarrhoea and rapid reddening of the face and neck. These tumours produce excessive amounts of certain natural compounds, which causes the symptoms (hormones). By preventing the synthesis of these hormones, this medicine works. Octreotide aids in minimising fluid and mineral loss by reducing watery diarrhoea.
Octreotide is also used to treat a disease known as acromegaly, which develops when the body produces an excessive amount of a natural chemical known as growth hormone. Acromegaly treatment lowers the chance of developing major conditions including diabetes and heart disease. Octreotide functions by bringing the level of growth hormone down to normal ranges. Octreotide does not treat these ailments. Octreotide is frequently used with other forms of therapy (e.g., surgery, radiation, other drugs). There are several brand names for octreotide, including Sandostatin and Sandostatin LAR.
The white salt C18H32CaN2O10 Calcium Pantothenate is a synthetic source of pantothenic acid. It's a nutritional supplement. It is used to address a lack of pantothenic acid (Vitamin B5).
In addition to its use in the treatment of these conditions, octreotide is also used in the management of other medical conditions, including bleeding esophageal varices, refractory hypoglycemia, and dumping syndrome, a condition that can occur after gastric surgery.
Read More- https://coherentmarketinsightsus.blogspot.com/2023/03/octreotide-is-synthetic-peptide-drug.html
